Related references
Note: Only part of the references are listed.Heme oxygenase-1 induction in the brain during lipopolysaccharide-induced acute inflammation
Shigeru Maeda
Neuropsychiatric Disease and Treatment (2011)
Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients
Xinglong Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease
P. Hemachandra Reddy et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Insights into amyloid-β-induced mitochondrial dysfunction in Alzheimer disease
Xinglong Wang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-β peptide
Takaaki Hayashi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Three histidine residues of amyloid-β peptide control the redox activity of copper and iron
M. Nakamura et al.
BIOCHEMISTRY (2007)
Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment
William R. Markesbery et al.
ARCHIVES OF NEUROLOGY (2007)
Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease
M. C. Polidori et al.
AMINO ACIDS (2007)
Increases in luteinizing hormone are associated with declines in cognitive performance
Gemma Casadesus et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP/PS1 mice without affecting β-amyloid burden
Tarja M. Malm et al.
JOURNAL OF NEUROSCIENCE (2007)
Mortality in randomized trials of antioxidant supplements for primary and secondary prevention - Systematic review and meta-analysis
Goran Bjelakovic et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Chronic dietary α-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice
Joseph F. Quinn et al.
NEUROBIOLOGY OF AGING (2007)
Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and α-lipoic acid against HNE-mediated oxidative stress and neurotoxicity:: Implications for Alzheimer's disease
Hafiz Mohammad Abdul et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Is antioxidant therapy a viable alternative for mild cognitive impairment? Examination of the evidence
Marie-Laure Ancelin et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Lipoic acid and n-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts
Paula I. Moreira et al.
JOURNAL OF ALZHEIMERS DISEASE (2007)
Lipoic acid as a novel treatment for Alzheimer's disease and related dementias
Lina Holmquist et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Chronic systemic D-galactose exposure induces memory loss, neuro degeneration, and oxidative damage in mice:: Protective effects of R-α-lipoic acid
Xu Cui et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Involvement of oxidative stress in Alzheimer disease
Akihiko Nunomura et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Luteinizing hormone modulates cognition and amyloid-deposition in Alzheimer APP transgenic mice
G Casadesus et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2006)
The (un)balance between metabolic and oxidative abnormalities and cellular compensatory responses in Alzheimer disease
Paula I. Moreira et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2006)
Neuropathology of Alzheimer disease: pathognomonic but not pathogenic
Rudy J. Castellani et al.
ACTA NEUROPATHOLOGICA (2006)
Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L Tau transgenic mice
DC David et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron
K Honda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment
LJ Thal et al.
NEUROPSYCHOPHARMACOLOGY (2005)
The protective role of DL-α-lipoic acid in biogenic amines catabolism triggered by Aβ amyloid vaccination in mice
EP Jesudason et al.
BRAIN RESEARCH BULLETIN (2005)
Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations
Q Liu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Oxidative imbalance in Alzheimer's disease
XW Zhu et al.
MOLECULAR NEUROBIOLOGY (2005)
Alzheimer's disease: the two-hit hypothesis
XW Zhu et al.
LANCET NEUROLOGY (2004)
α-Lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis
M Morini et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Effects of α-tocopherol on an animal model of tauopathies
H Nakashima et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease
A Nunomura et al.
NEUROBIOLOGY OF DISEASE (2004)
Oxidative stress and neuronal adaptation in Alzheimer disease: The role of SAPK pathways
XW Zhu et al.
ANTIOXIDANTS & REDOX SIGNALING (2003)
Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model
JA Joseph et al.
NUTRITIONAL NEUROSCIENCE (2003)
Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants
G Veurink et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells
A Gómez-Ramos et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
The antioxidants α-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice
SA Farr et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Early Vitamin E supplementation in young but not aged mice reduces A beta levels and amyloid deposition in a transgenic model of Alzheimer's disease
S Sung et al.
FASEB JOURNAL (2003)
Advanced glycation endproducts cause lipid peroxidation in the human neuronal cell line SH-SY5Y
Jovana Gasic-Milenkovic et al.
JOURNAL OF ALZHEIMERS DISEASE (2003)
Amyloid-β and τ serve antioxidant functions in the aging and Alzheimer brain
MA Smith et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Heme oxygenase-1: Molecular mechanisms of gene expression in oxygen-related stress
SW Ryter et al.
ANTIOXIDANTS & REDOX SIGNALING (2002)
The state versus amyloid-β:: the trial of the most wanted criminal in Alzheimer disease
CA Rottkamp et al.
PEPTIDES (2002)
Predicting the failure of amyloid-β vaccine
MA Smith et al.
LANCET (2002)
Antioxidant strategies for Alzheimer's disease
M Grundman et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2002)
Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months
DL King et al.
PHYSIOLOGY & BEHAVIOR (2002)
Oxidative damage is the earliest event in Alzheimer disease
A Nunomura et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Active glycation in neurofibrillary pathology of Alzheimer disease:: Nε-(carboxymethyl) lysine and hexitol-lysine
RJ Castellani et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Mitochondrial abnormalities in Alzheimer's disease
K Hirai et al.
JOURNAL OF NEUROSCIENCE (2001)
Cell death after exposure to subarachnoid hemolysate correlates inversely with expression of CuZn-Superoxide dismutase
PG Matz et al.
STROKE (2000)
In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: A central role for bound transition metals
LM Sayre et al.
JOURNAL OF NEUROCHEMISTRY (2000)
In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification
A Takeda et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Conformational change as one of the earliest alterations of tan in Alzheimer's disease
CL Weaver et al.
NEUROBIOLOGY OF AGING (2000)
Share Paper
